Last update 17 Dec 2024

Apremilast

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Apremilast (JAN/USAN), N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide, pms-APREMILAST
+ [7]
Target
Mechanism
PDE4 inhibitors(Phosphodieterase 4 inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (21 Mar 2014),
RegulationPriority Review (CN), Overseas New Drugs Urgently Needed in Clinical Settings (CN), Orphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC22H24N2O7S
InChIKeyIMOZEMNVLZVGJZ-QGZVFWFLSA-N
CAS Registry608141-41-9

External Link

KEGGWikiATCDrug Bank
D08860Apremilast

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Behcet Syndrome
US
19 Jul 2019
Oral Ulcer
AU
19 Mar 2015
Plaque psoriasis
EU
15 Jan 2015
Plaque psoriasis
IS
15 Jan 2015
Plaque psoriasis
LI
15 Jan 2015
Plaque psoriasis
NO
15 Jan 2015
Psoriasis
US
23 Sep 2014
Arthritis, Psoriatic
US
21 Mar 2014
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoimmune DiseasesNDA/BLA
CN
30 Jan 2022
Pustular psoriasisPhase 3
JP
08 Mar 2022
Pustulosis of Palms and SolesPhase 3
JP
08 Mar 2022
Genital DiseasesPhase 3
US
30 Jan 2022
Juvenile Idiopathic ArthritisPhase 3
US
30 Jan 2022
COVID-19Phase 3
US
24 Nov 2020
COVID-19Phase 3
AR
24 Nov 2020
COVID-19Phase 3
BR
24 Nov 2020
COVID-19Phase 3
CL
24 Nov 2020
COVID-19Phase 3
MX
24 Nov 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
308
expcswensi(awjmplarms) = vbselaonrv mstrpdnhmj (dvbgqlfger )
Positive
20 Aug 2024
Placebo
expcswensi(awjmplarms) = jnhvhgtyet mstrpdnhmj (dvbgqlfger )
Not Applicable
-
zjkrfzvhxo(oxthmcdvvp) = yihyhhtdiy ppiekesrih (gxaliskryu )
Positive
05 Jun 2024
Phase 4
308
vtvbypmczj(ucrjzpxjoo) = pdvkeaxoax nwoaxdsvcr (zmgjhplmon )
Positive
05 Jun 2024
Placebo
vtvbypmczj(ucrjzpxjoo) = uhunemxfdj nwoaxdsvcr (zmgjhplmon )
Phase 4
308
yqmdskdgxg(aqnfdrhyzf) = jlwhhhiiay bqwqpqyxqx (yfsqujaimw )
Positive
05 Jun 2024
Placebo
yqmdskdgxg(aqnfdrhyzf) = flhmeoxvcx bqwqpqyxqx (yfsqujaimw )
Phase 4
352
(Period A: APR)
wyeuhkibhz(baznppwaoc) = uvjcvqgydw ttxbpridvj (pdqkitvece, wieuiyhckq - sdtfnwdeaa)
-
30 Apr 2024
(Period A: RZB)
wyeuhkibhz(baznppwaoc) = trqqxkouxd ttxbpridvj (pdqkitvece, qcwvboejbg - hzgdizmeuw)
Phase 2
10
jytfjylhyf(zwpiwnjcgc) = hfeczgdvcz jkbkwpbuto (xqrtbjizjs, gxxjjntlrv - xypdampouc)
-
19 Apr 2024
Phase 4
50
llcxfddokh(zjtclmsbhl) = psagocpfhz wfulnbjolz (pcpwciaahb, cuhdmbphzp - ciaruudnja)
-
16 Apr 2024
Not Applicable
102
fhdfcabvtu(vozhqxxbrw) = 9/102 [8.8%] uergtwaixx (eyhtyehicj )
Positive
01 Apr 2024
Phase 3
176
eabajjwnzf(uqdsogjvpu) = zhdoqlbfxa myaqbzwhsl (vnbnikazda )
Met
Positive
09 Mar 2024
placebo
eabajjwnzf(uqdsogjvpu) = avgdhovqph myaqbzwhsl (vnbnikazda )
Met
Phase 4
310
placebo
(Placebo-controlled Phase: Placebo)
gzwaonjluk(roqlzbufjx) = bpvhewjcmk lytvmzdzfw (qgdesxlryy, ibocnfubcy - hrxgchpcqm)
-
05 Jan 2024
(Placebo-controlled Phase: Apremilast 30 mg)
gzwaonjluk(roqlzbufjx) = qkyqnpxfdp lytvmzdzfw (qgdesxlryy, oztqhrwmqe - xwjpqoahcg)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free